About me
Marc Martinell is the founder and CEO of Minoryx Therapeutics, a Spanish biotechnology company specializing in the development of innovative treatments for rare diseases of the central nervous system (CNS). Martinell has also worked at other companies in the sector, such as Oryzon Genomics and Crystax Pharmaceuticals. The CEO of Minoryx Therapeutics holds a degree in Chemistry from the University of Barcelona (UB) and a PhD in molecular recognition.
